Seoul, Seoul-t'ukpyolsi, South Korea UTC Investment Co. is the famous VC, which was founded in 1988. The main department of described VC is located in the Seoul. The company was established in Asia in South Korea.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the UTC Investment Co., startups are often financed by SunStates Fund, SFPI-FPIM, MPM Capital. The meaningful sponsors for the fund in investment in the same round are UBS Oncology Impact Fund, Surveyor Capital, Sphera Funds Management.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Oncorus.
Related Funds
Funds with similar focus
| Fund Name | Location |
| epiST | Japan, Tokyo |
| KDDI Open Innovation Fund | Chiyoda, Japan |
| LIGHTHOUSE | Beijing, Beijing, China |
| Miniclip | Neuchatel, Neuchâtel, Switzerland |
| National Petrochemical Industrial Company | - |
| New Energy Capital | Germany, Hanover, Niedersachsen |
| Oxford Investment Consultants LLP | Oxford, Oxfordshire, United Kingdom |
| Shanghai Commercial & Savings Bank | Taipei, Taiwan |
| The We Company | New York, New York, United States |
| V-Bio Ventures | Belgium, Gent, Oost-Vlaanderen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Lucas | 02 Oct 2024 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | |||
Allround Doctors | $6M | 06 Aug 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Bold9 | 07 Feb 2024 | South Korea, Gangwon-do, South Korea | |||
GEXVal | $4M | 04 Dec 2023 | Fujisawa, Kanagawa Prefecture, Japan | ||
Novorex | $10M | 24 Nov 2023 | Seongnam, Kyonggi-do, South Korea | ||
Right Route | $2M | 04 Apr 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Fatiabgen | $1M | 01 Jan 2023 | Pyongyang, Pyongyang, North Korea | ||
NUVI lab | $7M | 07 Sep 2022 | Kyonggi-do, Gyeonggi-do, South Korea | ||
Avelos Therapeutics | $8M | 22 Aug 2022 | Seoul, Seoul-t'ukpyolsi, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Lucas | 02 Oct 2024 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | |||
Allround Doctors | $6M | 06 Aug 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Bold9 | 07 Feb 2024 | South Korea, Gangwon-do, South Korea | |||
GEXVal | $4M | 04 Dec 2023 | Fujisawa, Kanagawa Prefecture, Japan | ||
Novorex | $10M | 24 Nov 2023 | Seongnam, Kyonggi-do, South Korea | ||
Right Route | $2M | 04 Apr 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Fatiabgen | $1M | 01 Jan 2023 | Pyongyang, Pyongyang, North Korea | ||
NUVI lab | $7M | 07 Sep 2022 | Kyonggi-do, Gyeonggi-do, South Korea | ||
Avelos Therapeutics | $8M | 22 Aug 2022 | Seoul, Seoul-t'ukpyolsi, South Korea |
